Determinants of Achieving Minimal Manifestations and Drug-free remission in Multifocal Motor Neuropathy (P4-11.022)

Although most patients with multifocal motor neuropathy (MMN) respond to intravenous immunoglobulin, many experience residual disability and are dependent on chronic immunotherapy. The frequency of patients achieving minimal manifestations (MM) and predictors of MM status are unknown. This study aims to determine (1) frequency of patients achieving MM, (2) frequency of drug-free remission, and (3) predictors of MM or drug-free remission.